Skip to main content

Prescribing guidance

Material to support appropriate prescribing of hypnotics and anxiolytics across Wales
21/07/2021

This educational pack aims to support the appropriate prescribing of hypnotics and anxiolytics across Wales by providing key health professionals with a practical approach for the initiation and review of hypnotic and anxiolytic prescribing.

Prescribing dilemmas: A guide for prescribers
06/07/2021

This document provides guidance for healthcare professionals regarding prescribing duration, foodstuffs, complementary medicines and alternative therapies, common ailments, fertility treatment, erectile dysfunction, prescribing for self and family, visitors from overseas, travel and occupational health vaccines, prescribing situations not covered by the NHS including private care and private prescriptions, unlicensed medicines and prescribing outside national guidance.

Initial clinical management of adult smokers in secondary care
02/06/2021

This document aims to inform and guide healthcare staff in NHS Wales about how to start nicotine replacement therapy (NRT) to manage nicotine withdrawal in adults who smoke and are admitted to hospital (secondary care).

Welsh national standards for medication review
02/06/2021

The Welsh National Standards for Medication Review have been developed to provide a structured approach to medication review and are benchmarks for quality, with the aim of optimising patient safety and prescribing practice.

Items identified as low value for prescribing in NHS Wales
21/05/2021

The aim of these documents is to minimise the prescribing of medicines that offer a limited clinical benefit to patients and where more cost effective treatments may be available.

Shared care prescribing and monitoring guidance
24/02/2021

This document updates the principles of best practice for shared care prescribing agreements.

Best practice reminder: Avoid nitrofurantoin in the treatment of pyelonephritis
24/02/2021

This short ‘Best Practice Reminder’ document has been developed to inform primary care prescribers about avoiding the prescribing of nitrofurantoin in patients with suspected pyelonephritis, the rationale behind this and what can be prescribed in its place.

Persistent pain resources
22/12/2020

This resource pack provides healthcare professionals with signposting and access to appropriate, relevant and up-to-date information on the non-pharmacological and pharmacological management of persistent (chronic) non-malignant pain in non-specialist settings.

Safeguarding users of opioid patches by standardising patient and caregiver counselling
22/12/2020

The aim of the counselling checklist is to assist healthcare professionals, working in community pharmacies, primary care and secondary care, in the essential counselling of patients on the safe and effective use of opioid patches.

All Wales Adult Asthma Management and Prescribing Guidelines
20/08/2020

This guideline aims to reduce variation in inhaler prescribing. Several audits in different health boards have demonstrated large variations in inhaler prescribing between different practices despite similar prevalence of asthma. Many health boards have produced local guidelines for asthma management, and it was discussed and agreed at Respiratory Health Implementation Group (RHIG) meetings that an All Wales guideline would be more effective than local plans.

All Wales Guidance for Health Boards/Trusts and Social Care Providers in Respect of Medicines and Care Support Workers
19/06/2020

This guidance is intended to provide managers, responsible individuals, registered nurses and care support workers in Welsh organisations with information on how and when a registered nurse may delegate the task of medicines support to a care support worker, and the necessary education and training standards, and policies and procedures that are required to facilitate this.

All Wales advice on oral anticoagulation for non-valvular atrial fibrillation
11/03/2020

This guideline focuses on treatment of patients with non-valvular atrial fibrillation (NVAF) and includes a Risk/Benefit Assessment Tool for Oral Anticoagulant Treatment and recommendations from ‘Warfarin Monitoring’ (published in June 2012) relevant to the treatment of NVAF.

Endocrine management of gender dysphoria in adults
14/11/2019

This document is intended for non-specialist practitioners engaged in the prescribing and monitoring of medical therapies used in the management of gender dysphoria.

All Wales COPD management and prescribing guideline
01/05/2019

This project aims to reduce variation in inhaler prescribing.

Guide to prescribing gluten-free products
30/11/2018

The All Wales Guide to Prescribing Gluten-free Products aims to support general practitioners and other healthcare professionals in the management of patients with coeliac disease, and aid the decision-making process in relation to prescribing Advisory Committee on Borderline Substances (ACBS)-approved gluten-free foods.

Primary care antimicrobial guidelines
30/07/2018

These guidelines aim to provide comprehensive standardised guidance for the use of antimicrobials/treatment of infections in primary care across Wales.

Safe use of proton pump inhibitors
28/02/2018

This document aims to highlight and help address the patient safety issues associated with the long-term use of proton pump inhibitors (PPIs) in adults.

Pharmacotherapy for smoking cessation
15/02/2018

This guide supports the appropriate prescribing and supply of smoking cessation pharmacotherapy in NHS Wales for smokers who are motivated to quit.

Common ailments formulary
08/02/2018

The Common Ailments service aims to improve patient access to consistent, evidence-based advice for the management of common ailments. The formulary was developed using recognised resources and involved multi-professional consultation to ensure the provision of consistent advice by pharmacists and GPs.

Multidisciplinary medicines reconciliation policy
30/06/2017

This policy document has been developed to provide healthcare professionals with information to promote the safe and timely completion of medicines reconciliation and provides guidance on completing the process.